EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY-NC-ND 4.0

Patch test in Brazilian children with a clinical diagnosis of atopic dermatitis: a cross-sectional study using an extended patch test battery

Janete Raad Rigolon, Simone Saintive Barbosa, Ekaterini Simões Goudouris

Allergologia et Immunopathologia · 2024

DOI: 10.15586/aei.v52i3.1024 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Allergologia et Immunopathologia, 2024. Verfasst von Janete Raad Rigolon und 2 weiteren Autor:innen. Beteiligte Einrichtung: Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil; janeteraad@yahoo.com.br. Hauptthemen laut MEDLINE: Patch Tests, Dermatitis, Atopic, Allergens. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Atopic dermatitis (AD) is a chronic and relapsing inflammatory skin disease mainly affecting children. Similarly, Allergic contact dermatitis (ACD) is an inflammatory skin disease, but unlike AD it results from direct exposure to an external agent. Theoretically, the impaired skin barrier facilitates the penetration of potential allergens. Therefore, AD patients are at risk for an associated ACD, exacerbating their skin condition. Because eczema is similar, performing a patch test (PT) for the differential diagnosis is essential.

Methods

In this cross-sectional transversal study, we performed a PT with 30 sensitizers in 26 children with AD, selected according to established criteria for suspected ACD, and treated at an AD center of a pediatric university hospital in Rio de Janeiro. Clinical presentation, patient profile, main sensitizers, and frequency of ACD caused by therapeutic skincare products were evaluated.

Results

In all, 23 (88.5%) patients reacted to at least one allergen, 21 (80.7%) had a relevant positive patch test, and 15 (57.7%) were polysensitized. The main positive sensitizers were nickel (38.5%), blue disperse (30.8%), fragrance mix (30.8%), and neomycin (23.1%). Nineteen (73%) patients reacted to substances present in therapeutic or skincare products.

Conclusion

Our data underscore the importance of performing a PT in AD children whose eczema has atypical distribution. The expressive percentage of positive tests, especially of allergens in skincare products, indicates the constant need to review the proposed treatments. Therefore, we recommend a specific and expanded PT battery for pediatric AD patients, including a negative control, to increase sensitivity for diagnosing ACD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Patch TestsDermatitis, AtopicAllergensHumansCross-Sectional StudiesChildFemaleMaleBrazilChild, PreschoolAdolescentDermatitis, Allergic ContactInfantDiagnosis, Differential

Stichwörter der Autor:innen

Adolescentallergic contact dermatitisatopic dermatitischildpatch test

Substanzen

Allergens

Autor:innen und Institutionen

  • Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil; janeteraad@yahoo.com.br.
  • Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.

Zitieren

APA

Rigolon, J. R., Barbosa, S. S., & Goudouris, E. S. (2024). Patch test in Brazilian children with a clinical diagnosis of atopic dermatitis: a cross-sectional study using an extended patch test battery. Allergologia et Immunopathologia. https://doi.org/10.15586/aei.v52i3.1024

Vancouver

Rigolon JR, Barbosa SS, Goudouris ES. Patch test in Brazilian children with a clinical diagnosis of atopic dermatitis: a cross-sectional study using an extended patch test battery. Allergologia et Immunopathologia. 2024. doi:10.15586/aei.v52i3.1024

BibTeX
@article{Rigolon2024,
  author = {Rigolon, Janete Raad and Barbosa, Simone Saintive and Goudouris, Ekaterini Simões},
  title = {Patch test in Brazilian children with a clinical diagnosis of atopic dermatitis: a cross-sectional study using an extended patch test battery},
  journal = {Allergologia et Immunopathologia},
  year = {2024},
  doi = {10.15586/aei.v52i3.1024}
}
Kostenlos starten →